May 5, 2020 / 10:04 PM / 22 days ago

BRIEF-Aquestive Therapeutics Reports First Quarter 2020 Financial Results And Provides Business Update Aqst-108 And Libervant Remain On Track

May 5 (Reuters) - Aquestive Therapeutics Inc:

* AQUESTIVE THERAPEUTICS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE: AQST-108 AND LIBERVANT REMAIN ON TRACK

* Q1 LOSS PER SHARE $0.49

* Q1 REVENUE $8.8 MILLION VERSUS REFINITIV IBES ESTIMATE OF $10.1 MILLION

* Q1 EARNINGS PER SHARE ESTIMATE $-0.47 — REFINITIV IBES DATA

* REAFFIRMS FULL YEAR 2020 GUIDANCE INCLUDING REVENUE, ADJUSTED EBITDA AND CASH BURN Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below